½ÃÀ庸°í¼­
»óǰÄÚµå
1529780

Àڱà ¸Å´Ïǽ·¹ÀÌ¼Ç ±â±â ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)

Uterine Manipulation Devices Market Size, Share & Trends Analysis Report By Application (Total Laparoscopy Hysterectomy, Laparoscopic Supracervical Hysterectomy), By End-use, By Region, And Segment Forecasts, 2024 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 165 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Àڱà ¸Å´Ïǽ·¹ÀÌ¼Ç ±â±â ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View ResearchÀÇ ÃֽЏ®Æ÷Æ®¿¡ µû¸£¸é ¼¼°èÀÇ Àڱà ¸Å´Ïǽ·¹ÀÌ¼Ç ±â±â ½ÃÀå ±Ô¸ð´Â 2024-2030³â 5.93%ÀÇ CAGRÀ» ±â·ÏÇϸç, 2030³â¿¡´Â 4¾ï 2,179¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

ºÎÀΰú ÁúȯÀÇ ±Þ°ÝÇÑ Áõ°¡¿Í ÃÖ¼Ò Ä§½À ¼ö¼ú¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼­ ºÎÀΰú ÁúȯÀÇ À¯º´·ü Áõ°¡°¡ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

´Ù¾çÇÑ ºÎÀΰú ÁúȯÀÇ À¯º´·ü Áõ°¡, »ç¿ëÀÇ ¿ëÀ̼º ¹× ÆíÀǼºÀ¸·Î ÀÎÇÑ Àڱà Á¶ÀÛ ±â±âÀÇ Ã¤Åà Áõ°¡´Â ¿¹Ãø ±â°£ Áß ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ¿äÀÎ Áß ÇϳªÀ̸ç, UF Á¾¾çÀÇ À¯º´·üÀº ¿©¼ºÀÌ ³ªÀ̰¡ µé¾î°¨¿¡ µû¶ó Áõ°¡ÇÏ¿© 40-60¼¼ ¿©¼ºÀÇ 30% À̻󿡼­ ¹ß°ßµË´Ï´Ù. UF´Â º¸Åë 40´ë ÈĹݿ¡¼­ 50´ë Ãʹݿ¡ ¹ßº´ÇÏÁö¸¸, ÀϺΠ¿©¼ºÀº ´õ ¾î¸° ³ªÀÌ¿¡ ¹ßº´Çϱ⵵ ÇÕ´Ï´Ù. ÀÌó·³ UF·Î °íÅë¹Þ´Â ¿©¼ºÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Àڱà ÀûÃâ ¼ö¼ú °Ç¼ö°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â Àڱà ¸Å´Ïǽ·¹ÀÌ¼Ç ±â±â¿¡ ´ëÇÑ Å« ¼ö¿ä·Î À̾îÁö°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ ¿©·¯ ÁÖ¿ä ±â¾÷ÀÌ Çõ½ÅÀûÀÎ Àúħ½À ¹× ºñħ½À ¼ö¼ú±â±¸¸¦ Ãâ½ÃÇϱâ À§ÇØ ¿¬±¸°³¹ß¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ÇöÀç ½ÃÀå¿¡´Â ´Ù¾çÇÑ Ã·´Ü Á¶À۱Ⱑ ÆÇ¸ÅµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ÀΰøÇ×¹® ¼ö¼úÀÇ °æ¿ì ÀϹÝÀûÀ¸·Î ÀڱðæºÎ¿¡ ¸Â´Â ÄÅÀÌ ´Þ¸° Á¶À۱Ⱑ ¼±È£µÇ´Âµ¥, RUMI¿Í KOH ÄÅÀÇ Á¶ÇÕ(CooperSurgical)À̳ª VCare(CONMED)¿Í °°Àº Á¶À۱Ⱑ ´ëÇ¥ÀûÀÔ´Ï´Ù. µû¶ó¼­ ÀÌ·¯ÇÑ ±â±¸µéÀÌ Á¦°øÇÏ´Â ´Ù¾çÇÑ ÀåÁ¡µéÀÌ ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½ÃŰ°í ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

Àڱà ¸Å´Ïǽ·¹ÀÌ¼Ç ±â±â ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ® :

  • ¿ëµµº°·Î´Â º¹°­°æ ÀÚ±ÃÀüÀýÁ¦¼ú(TLH)ÀÌ 2023³â 38.33%ÀÇ ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÃÖ¼Òħ½ÀÀû ¼ö¼ú¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼­ ÀÌ ºÐ¾ßÀÇ ¼ºÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.
  • ÃÖÁ¾ ¿ëµµº°·Î´Â º´¿ø ºÎ¹®ÀÌ 2023³â 59.37%ÀÇ ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀº ´Ù¾çÇÑ ºÎÀΰú ÁúȯÀ» ¾Î°í Àִ ȯÀÚ ¼ö°¡ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù.
  • Áß³²¹Ì ½ÃÀåÀº ºÎÀΰú ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ºê¶óÁú, ¾Æ¸£ÇîÆ¼³ª¿Í °°Àº ±¹°¡µé¿¡¼­ Àڱ󻸷Áõ¿¡ ´ëÇÑ ÀνÄÀ» Á¦°øÇϱâ À§ÇÑ ±¸»óÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ Áß °¡Àå ºü¸¥ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå °³¿ä

Á¦3Àå Àڱà ¸Å´Ïǽ·¹ÀÌ¼Ç ±â±â ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • º¸Á¶ ½ÃÀåÀÇ Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • Àڱà ¸Å´Ïǽ·¹ÀÌ¼Ç ±â±â ½ÃÀå ºÐ¼® Åø
    • ¾÷°è ºÐ¼® - PorterÀÇ »ê¾÷ ºÐ¼®
    • PESTEL ºÐ¼®

Á¦4Àå Àڱà ¸Å´Ïǽ·¹ÀÌ¼Ç ±â±â ½ÃÀå : ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ Àڱà ¸Å´Ïǽ·¹ÀÌ¼Ç ±â±â ½ÃÀåÀÇ º¯µ¿ ºÐ¼®
  • ¼¼°èÀÇ Àڱà ¸Å´Ïǽ·¹ÀÌ¼Ç ±â±â ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, ¿ëµµº°, 2018-2030³â
  • º¹°­°æÇÏ Àڱà ÀüÀûÃâ¼ú(TLH)
  • º¹°­°æÇÏ ÀڱðæºÎ ÀýÁ¦¼ú(LSH)
  • º¹°­°æ º¸Á¶ Áú½Ä Àڱà ÀûÃâ¼ú(LAVH)
  • ¼±°ñÁú °íÁ¤¼ú
  • ±âŸ

Á¦5Àå Àڱà ¸Å´Ïǽ·¹ÀÌ¼Ç ±â±â ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ Àڱà ¸Å´Ïǽ·¹ÀÌ¼Ç ±â±â ½ÃÀåÀÇ º¯µ¿ ºÐ¼®
  • ¼¼°èÀÇ Àڱà ¸Å´Ïǽ·¹ÀÌ¼Ç ±â±â ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, ÃÖÁ¾ ¿ëµµº°, 2018-2030³â
  • º´¿ø
  • Ŭ¸®´Ð
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ(ASC)

Á¦6Àå Àڱà ¸Å´Ïǽ·¹ÀÌ¼Ç ±â±â ½ÃÀå : Áö¿ªº° ÃßÁ¤¡¤µ¿Ç⠺м®(¿ëµµº°, ÃÖÁ¾ ¿ëµµº°)

  • Áö¿ª ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®, 2018-2030³â
  • ºÏ¹Ì
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦7Àå °æÀï ±¸µµ

  • ½ÃÀå Âü¿© ±â¾÷ÀÇ ºÐ·ù
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • Conkin Surgical Instrument Ltd.
    • CooperSurgical Inc.
    • B. Braun SE
    • KARL STORZ SE &Co. KG
    • CONMED Corporation
    • Richard Wolf GmbH
    • Utah Medical Products, Inc
    • Purple Surgical
    • Laborie
    • LSI Solutions, Inc.
  • È÷Æ®¸Ê ºÐ¼®/±â¾÷ ½ÃÀå ÇöȲ ºÐ¼®
  • 2023³â ±â¾÷ ½ÃÀå Á¡À¯À² ÃßÁ¤ ºÐ¼®
  • ±âŸ ÁÖ¿ä ½ÃÀå ±â¾÷ ¸®½ºÆ®
KSA 24.08.28

Uterine Manipulation Devices Market Growth & Trends:

The global uterine manipulation devices market size is expected to reach USD 421.79 million by 2030, registering a CAGR of 5.93% from 2024 to 2030, according to a new report by Grand View Research, Inc. A surge in the prevalence of gynecological diseases, coupled with the rising preference for minimally invasive surgical procedures, is a key driving factor for the market.

The increasing prevalence of various gynecological disorders and the growing adoption of uterine manipulation devices owing to their ease of use and convenience are among factors expected to boost the market growth during the forecast period. The prevalence of UF tumors increases as women grow older and it is prevalent in over 30% of women aged between 40 and 60. UF usually develops in women in their late 40s and early 50s, though in some women it may occur at a younger age. Thus, the increasing number of women suffering from UF has led to a rise in the number of hysterectomy procedures, leading to significant demand for uterine manipulation devices.

Moreover, several key players are investing in R&D for the launch of innovative minimally and noninvasive surgical instruments. Currently, various advanced manipulators are available in the market. For instance, during colpotomy procedure, usually manipulators with a cup to fit over the cervix are preferred. These include RUMI in combination with KOH cups (by CooperSurgical, Inc.) and VCare (by CONMED Corporation). Therefore, various advantages offered by these devices are cumulatively responsible for boosting the demand for minimally invasive procedures, thereby propelling the market growth.

Uterine Manipulation Devices Market Report Highlights:

  • In terms of application, the total laparoscopic hysterectomy (TLH) dominated the market with a revenue share of 38.33% in 2023. The growing preference for minimally invasive procedures is the major factor propelling the segment growth
  • In terms of end-use, the hospital segment dominated the market with a revenue share of 59.37% in 2023. The segment growth is majorly attributed to the increase in the number of patients suffering from various gynecological conditions
  • The Latin America market is expected to witness the fastest growth over the forecast period due to the rising prevalence of gynecological disorders and increasing initiatives to provide awareness of endometriosis across the countries like Brazil and Argentina

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Uterine Manipulation Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of gynecological disorders
      • 3.2.1.2. Rising adoption of minimally invasive procedures
      • 3.2.1.3. Growing adoption of technologically advanced devices for hysteroscopy procedures
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Rise in gynecologic surgical costs
      • 3.2.2.2. Concerns associated with product approval and commercialization
      • 3.2.2.3. Risk of complications associated with uterine manipulation devices
  • 3.3. Uterine Manipulation Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Uterine Manipulation Devices Market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Uterine Manipulation Devices Market Movement Analysis
  • 4.3. Global Uterine Manipulation Devices Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 4.4. Total Laparoscopy Hysterectomy (TLH)
    • 4.4.1. Total Laparoscopy Hysterectomy (TLH) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Laparoscopic Supracervical Hysterectomy (LSH)
    • 4.5.1. Laparoscopic Supracervical Hysterectomy (LSH) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Laparoscopically Assisted Vaginal Hysterectomy (LAVH)
    • 4.6.1. Laparoscopically Assisted Vaginal Hysterectomy (LAVH) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Sacrocolpopexy
    • 4.7.1. Sacrocolpopexy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Uterine Manipulation Devices Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Uterine Manipulation Devices Market Movement Analysis
  • 5.3. Global Uterine Manipulation Devices Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Clinics
    • 5.5.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Ambulatory Surgery Centers (ASCs)
    • 5.6.1. Ambulatory Surgery Centers (ASCs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Uterine Manipulation Devices Market: Regional Estimates & Trend Analysis By Application, By End Use

  • 6.1. Regional Dashboard
  • 6.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. North America Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Scenario
      • 6.3.2.4. Reimbursement Scenario
      • 6.3.2.5. U.S. Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Scenario
      • 6.3.3.4. Reimbursement Scenario
      • 6.3.3.5. Canada Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Scenario
      • 6.3.4.4. Reimbursement Scenario
      • 6.3.4.5. Mexico Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Scenario
      • 6.4.2.4. Reimbursement Scenario
      • 6.4.2.5. UK Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Scenario
      • 6.4.3.4. Reimbursement Scenario
      • 6.4.3.5. Germany Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Scenario
      • 6.4.4.4. Reimbursement Scenario
      • 6.4.4.5. France Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Scenario
      • 6.4.5.4. Reimbursement Scenario
      • 6.4.5.5. Italy Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Scenario
      • 6.4.6.4. Reimbursement Scenario
      • 6.4.6.5. Spain Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Denmark
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Scenario
      • 6.4.7.4. Reimbursement Scenario
      • 6.4.7.5. Denmark Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.8. Sweden
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Competitive Scenario
      • 6.4.8.3. Regulatory Scenario
      • 6.4.8.4. Reimbursement Scenario
      • 6.4.8.5. Sweden Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.9. Norway
      • 6.4.9.1. Key Country Dynamics
      • 6.4.9.2. Competitive Scenario
      • 6.4.9.3. Regulatory Scenario
      • 6.4.9.4. Reimbursement Scenario
      • 6.4.9.5. Norway Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Scenario
      • 6.5.2.4. Reimbursement Scenario
      • 6.5.2.5. Japan Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. China
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Scenario
      • 6.5.3.4. Reimbursement Scenario
      • 6.5.3.5. China Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Scenario
      • 6.5.4.4. Reimbursement Scenario
      • 6.5.4.5. India Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Scenario
      • 6.5.5.4. Reimbursement Scenario
      • 6.5.5.5. South Korea Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Australia
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Scenario
      • 6.5.6.4. Reimbursement Scenario
      • 6.5.6.5. Australia Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Thailand
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Scenario
      • 6.5.7.4. Reimbursement Scenario
      • 6.5.7.5. Thailand Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Scenario
      • 6.6.2.4. Reimbursement Scenario
      • 6.6.2.5. Brazil Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Scenario
      • 6.6.3.4. Reimbursement Scenario
      • 6.6.3.5. Argentina Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Middle East & Africa
    • 6.7.1. Middle East & Africa Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Scenario
      • 6.7.2.4. Reimbursement Scenario
      • 6.7.2.5. South Africa Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Saudi Arabia
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Scenario
      • 6.7.3.4. Reimbursement Scenario
      • 6.7.3.5. Saudi Arabia Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.3. Regulatory Scenario
      • 6.7.4.4. Reimbursement Scenario
      • 6.7.4.5. UAE Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Scenario
      • 6.7.5.4. Reimbursement Scenario
      • 6.7.5.5. Kuwait Uterine Manipulation Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Key Company Profiles
    • 7.2.1. Conkin Surgical Instrument Ltd.
      • 7.2.1.1. Company Overview
      • 7.2.1.2. Financial Performance
      • 7.2.1.3. Service Benchmarking
      • 7.2.1.4. Strategic Initiatives
    • 7.2.2. CooperSurgical Inc.
      • 7.2.2.1. Company Overview
      • 7.2.2.2. Financial Performance
      • 7.2.2.3. Service Benchmarking
      • 7.2.2.4. Strategic Initiatives
    • 7.2.3. B. Braun SE
      • 7.2.3.1. Company Overview
      • 7.2.3.2. Financial Performance
      • 7.2.3.3. Product Benchmarking
      • 7.2.3.4. Strategic Initiatives
    • 7.2.4. KARL STORZ SE & Co. KG
      • 7.2.4.1. Company Overview
      • 7.2.4.2. Financial Performance
      • 7.2.4.3. Product Benchmarking
      • 7.2.4.4. Strategic Initiatives
    • 7.2.5. CONMED Corporation
      • 7.2.5.1. Company Overview
      • 7.2.5.2. Financial Performance
      • 7.2.5.3. Product Benchmarking
      • 7.2.5.4. Strategic Initiatives
    • 7.2.6. Richard Wolf GmbH
      • 7.2.6.1. Company Overview
      • 7.2.6.2. Financial Performance
      • 7.2.6.3. Product Benchmarking
      • 7.2.6.4. Strategic Initiatives
    • 7.2.7. Utah Medical Products, Inc
      • 7.2.7.1. Company Overview
      • 7.2.7.2. Financial Performance
      • 7.2.7.3. Product Benchmarking
      • 7.2.7.4. Strategic Initiatives
    • 7.2.8. Purple Surgical
      • 7.2.8.1. Company Overview
      • 7.2.8.2. Financial Performance
      • 7.2.8.3. Product Benchmarking
      • 7.2.8.4. Strategic Initiatives
    • 7.2.9. Laborie
      • 7.2.9.1. Company Overview
      • 7.2.9.2. Financial Performance
      • 7.2.9.3. Product Benchmarking
      • 7.2.9.4. Strategic Initiatives
    • 7.2.10. LSI Solutions, Inc.
      • 7.2.10.1. Company Overview
      • 7.2.10.2. Financial Performance
      • 7.2.10.3. Product Benchmarking
      • 7.2.10.4. Strategic Initiatives
  • 7.3. Heat Map Analysis/ Company Market Position Analysis
  • 7.4. Estimated Company Market Share Analysis, 2023
  • 7.5. List of Other Key Market Players
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦